Evaluating the Safety of Combined Ipilimumab and Radiotherapy for the Treatment of Metastatic Melanoma

被引：0
|
作者：
Postow, Michael A. [1 ]
Barker, Christopher A. [1 ]
Khan, Shaheer A. [1 ]
Wolchok, Jedd D. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF IMMUNOTHERAPY | 2012年 / 35卷 / 09期
关键词：
Melanoma immunotherapy; Abscopal; CTLA-4;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：733 / 733
页数：1
相关论文
共 50 条
  • [21] Ipilimumab for metastatic uveal melanoma
    Gilbert, Judith A.
    LANCET ONCOLOGY, 2013, 14 (10): : E394 - E394
  • [22] Ipilimumab with fotemustine in metastatic melanoma
    Garbe, Claus
    LANCET ONCOLOGY, 2012, 13 (09): : 851 - 852
  • [23] Ipilimumab for advanced metastatic melanoma
    Starz, Hans
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (08) : 981 - 982
  • [24] Ipilimumab (Yervoy) for Metastatic Melanoma
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2011, 53 (1367): : 51 - 52
  • [25] IPILIMUMAB IN PRETREATED METASTATIC UVEAL MELANOMA PATIENTS: SAFETY AND CLINICAL EFFICACY
    Danielli, Riccardo
    Queirolo, Paola
    Testori, Alessandro
    Plummer, Ruth
    Razis, Evangelia
    Sileni, Vanna Chiarion
    Calabro, Luana
    Di Giacomo, Anna Maria
    Ridolfi, Ruggero
    Maio, Michele
    ANNALS OF ONCOLOGY, 2009, 20
  • [26] Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy
    Danielli, Riccardo
    Ridolfi, Ruggero
    Chiarion-Sileni, Vanna
    Queirolo, Paola
    Testori, Alessandro
    Plummer, Ruth
    Boitano, Monica
    Calabro, Luana
    De Rossi, Costanza
    Di Giacomo, Anna Maria
    Ferrucci, Pier Francesco
    Ridolfi, Laura
    Altomonte, Maresa
    Miracco, Clelia
    Balestrazzi, Angelo
    Maio, Michele
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2012, 61 (01) : 41 - 48
  • [27] Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy
    Riccardo Danielli
    Ruggero Ridolfi
    Vanna Chiarion-Sileni
    Paola Queirolo
    Alessandro Testori
    Ruth Plummer
    Monica Boitano
    Luana Calabrò
    Costanza De Rossi
    Anna Maria Di Giacomo
    Pier Francesco Ferrucci
    Laura Ridolfi
    Maresa Altomonte
    Clelia Miracco
    Angelo Balestrazzi
    Michele Maio
    Cancer Immunology, Immunotherapy, 2012, 61 : 41 - 48
  • [28] Ipilimumab in pretreated metastatic uveal melanoma patients: safety and clinical efficacy
    Danielli, R.
    Queirolo, P.
    Testori, A.
    Plummer, R.
    Razi, E.
    Sileni, V. Chiarion
    Calabro, L.
    Di Giacomo, A. M.
    Ridolfi, R.
    Maio, M.
    EJC SUPPLEMENTS, 2009, 7 (02): : 581 - 581
  • [29] Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma
    Kelderman, Sander
    Heemskerk, Bianca
    van Tinteren, Harm
    van den Brom, Rob R. H.
    Hospers, Geke A. P.
    van den Eertwegh, Alfonsus J. M.
    Kapiteijn, Ellen W.
    de Groot, Jan Willem B.
    Soetekouw, Patricia
    Jansen, Rob L.
    Fiets, Edward
    Furness, Andrew J. S.
    Renn, Alexandra
    Krzystanek, Marcin
    Szallasi, Zoltan
    Lorigan, Paul
    Gore, Martin E.
    Schumacher, Ton N. M.
    Haanen, John B. A. G.
    Larkin, James M. G.
    Blank, Christian U.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2014, 63 (05) : 449 - 458
  • [30] DISSEMINATED HERPES ZOSTER AFTER IPILIMUMAB TREATMENT FOR METASTATIC MELANOMA
    Russo, John P.
    Russo, Armand V.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2016, 31 : S601 - S602
12345